September 10, 2020 Comments Off on Patent delisted for Astrazeneca Ab drug BYDUREON Posted in: Uncategorized
Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are thirty patents…
The post Patent delisted for Astrazeneca Ab drug BYDUREON appeared first…
September 10, 2020 Comments Off on Patent delisted for Boehringer Ingelheim drug TRADJENTA Posted in: Uncategorized
Annual Drug Patent Expirations for TRADJENTA Tradjenta is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from three suppliers. There are nine patents…
The post Patent delisted for Boehringer Ingelheim drug TRADJENTA…
